Trial Profile
An independent observational study to compare the effectiveness of cytisine and nicotine replacement therapy (NRT) as an aid to smoking cessation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2018
Price :
$35
*
At a glance
- Drugs Cytisinicline (Primary) ; Nicotine replacement therapy
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 24 Sep 2018 New trial record
- 18 Sep 2018 According to an Achieve Life Sciences media release, data from this trial has been published in the International Journal of Drug Policy (August 2018).
- 18 Sep 2018 Results presented in the Achieve Life Sciences media release.